REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 90 filers reported holding REATA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $353,000 | +99.4% | 3,462 | +77.4% | 0.00% | – |
Q1 2023 | $177,000 | -0.6% | 1,951 | -58.3% | 0.00% | – |
Q4 2022 | $178,000 | +790.0% | 4,677 | +464.2% | 0.00% | – |
Q3 2022 | $20,000 | +122.2% | 829 | +185.9% | 0.00% | – |
Q2 2022 | $9,000 | -83.9% | 290 | -83.0% | 0.00% | – |
Q1 2022 | $56,000 | -62.2% | 1,708 | -69.5% | 0.00% | – |
Q4 2021 | $148,000 | -51.5% | 5,605 | +84.6% | 0.00% | – |
Q3 2021 | $305,000 | +12.5% | 3,037 | +58.9% | 0.00% | – |
Q2 2021 | $271,000 | -81.5% | 1,911 | -87.0% | 0.00% | – |
Q1 2021 | $1,462,000 | +2658.5% | 14,667 | +3318.9% | 0.00% | – |
Q4 2020 | $53,000 | +140.9% | 429 | +90.7% | 0.00% | – |
Q3 2020 | $22,000 | -98.9% | 225 | -98.3% | 0.00% | -100.0% |
Q2 2020 | $2,040,000 | +100.8% | 13,074 | +85.7% | 0.00% | – |
Q1 2020 | $1,016,000 | +936.7% | 7,039 | +1375.7% | 0.00% | – |
Q4 2019 | $98,000 | +512.5% | 477 | +138.5% | 0.00% | – |
Q3 2019 | $16,000 | -57.9% | 200 | -50.5% | 0.00% | – |
Q2 2019 | $38,000 | -19.1% | 404 | -27.1% | 0.00% | – |
Q1 2019 | $47,000 | +56.7% | 554 | +4.1% | 0.00% | – |
Q4 2018 | $30,000 | -57.7% | 532 | -38.8% | 0.00% | – |
Q3 2018 | $71,000 | +294.4% | 869 | +61.2% | 0.00% | – |
Q2 2018 | $18,000 | +800.0% | 539 | +433.7% | 0.00% | – |
Q1 2018 | $2,000 | -50.0% | 101 | -21.1% | 0.00% | – |
Q4 2017 | $4,000 | -88.6% | 128 | -88.7% | 0.00% | – |
Q3 2017 | $35,000 | +1650.0% | 1,131 | +1613.6% | 0.00% | – |
Q2 2017 | $2,000 | -50.0% | 66 | -66.2% | 0.00% | – |
Q1 2017 | $4,000 | +300.0% | 195 | +375.6% | 0.00% | – |
Q4 2016 | $1,000 | – | 41 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $288,821,000 | 55.24% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 100,000 | $9,970,000 | 15.20% |
Tolleson Wealth Management, Inc. | 108,000 | $10,768,000 | 3.25% |
MADDEN SECURITIES Corp | 34,787 | $3,468,000 | 2.03% |
Biondo Investment Advisors, LLC | 101,204 | $10,090,000 | 2.01% |
LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,027,000 | 1.91% |
Duquesne Family Office | 749,897 | $74,765,000 | 1.65% |
Sofinnova Investments, Inc. | 238,520 | $23,780,000 | 1.43% |
Camber Capital Management LP | 400,000 | $39,880,000 | 1.37% |
Integral Health Asset Management, LLC | 44,000 | $4,387,000 | 1.25% |